📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Recombinant infectious bronchitis virus containing mutations in non-structural proteins 10, 14, 15, and 16 and within the macrodomain provides complete protection against homologous challenge. (2025)

First Author: Keep S

Attributed to: Using synthetic biology to generate novel vaccines against avian infectious bronchitis virus (IBV) funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1128/jvi.01663-24

PubMed Identifier: 40013770

Publication URI: http://europepmc.org/abstract/MED/40013770

Type: Journal Article/Review

Parent Publication: Journal of virology

ISSN: 0022-538X